Fordel StudiosThe AI healthcare gold rush is here
What Happened
AI companies are clustering around healthcare and fast. In just the past week, OpenAI bought health startup Torch, Anthropic launched Claude for healthcare, and Sam Altman-backed MergeLabs closed a $250 million seed round at an $850 million valuation. The money and products are pouring into he
Our Take
Healthcare's smart because it has real ROI (faster diagnosis = fewer lawsuits + throughput) and regulatory moats (FDA approval = immunity from competition for years).
But 'gold rush' implies everyone wins. They won't. Three survive: one that nails hospital workflows, one that wins insurance data, one that builds the regulatory playbook. The rest burn capital on MVP demos.
Real risk? Overhyped expectations set back AI healthcare adoption five years when early wins don't scale.
What To Do
Track which AI health startups are actually deploying in hospitals vs. announcing partnerships; deployment friction is where 90% of them stall.
Cited By
React